SC
PFE icon

Stance Capital’s Pfizer PFE Stock Holding History

Stance Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-26,846
Closed -$668K – 308
2025
Q4 		$668K Buy
26,846
+26,746
+26,746% +$674K 0.25% 130
2025
Q3 		$2.55K Buy
+100
New +$2.47K ﹤0.01% 269
2025
Q1 		– Sell
-7,257
Closed -$193K – 215
2024
Q4 		$193K Buy
+7,257
New +$197K 0.12% 60

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Stance Capital's PFE Position: Q1 2026 in Review

Stance Capital sold out of Pfizer (PFE) in Q1 2026, closing a stake of 26,846 shares — an estimated $668K sold.

Stance Capital first reported a position in PFE in Q4 2024 and held it in 3 quarters. The position peaked at $668K in Q4 2025. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Stance Capital reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Stance Capital sold 26,846 Pfizer shares in Q1 2026, an estimated $668K.
  • Stance Capital first reported a position in Pfizer in Q4 2024 and held it in 3 quarters.
  • Stance Capital's Pfizer position peaked at $668K in Q4 2025.
  • 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Stance Capital's 13F filing for Q1 2026, filed 14 May 2026.